BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6173535)

  • 1. Cardiac effects of amrinone on rabbit papillary muscle and guinea pig Langendorff heart preparations.
    Onuaguluchi G; Tanz RD
    J Cardiovasc Pharmacol; 1981; 3(6):1342-55. PubMed ID: 6173535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses to amrinone in isolated cardiac muscles from cat, rabbit, and guinea pig.
    Siegl PK; Morgan G; Sweet CS
    J Cardiovasc Pharmacol; 1984; 6(2):281-7. PubMed ID: 6200717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotonic and coronary vasodilatatory effects of amrinone in the canine heart-lung preparation with a support dog as compared with those of dobutamine.
    Takeda K; Matsui K; Nakazawa M; Nakahara H; Imai H; Imai S
    Jpn J Pharmacol; 1986 Mar; 40(3):381-8. PubMed ID: 3012165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrical and mechanical effects of amrinone on isolated guinea pig ventricular muscle.
    Kondo N; Shibata S; Kodama I; Yamada K
    J Cardiovasc Pharmacol; 1983; 5(6):903-12. PubMed ID: 6196561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of amrinone on cardiac function, oxygen consumption and lactate production of an isolated, perfused, working guinea-pig heart.
    Zannad F; Juillere Y; Royer RJ
    Arch Int Pharmacodyn Ther; 1983 Jun; 263(2):264-71. PubMed ID: 6882099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiac effects of Cordemcura in vitro].
    Hagen A; Sonnenburg F; Frömmel B; Fischer R; Hennig R; Just E; Landmann H; Göres E
    Pharmazie; 1986 Mar; 41(3):186-9. PubMed ID: 3714791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of levosimendan on myocardial function in ropivacaine toxicity in isolated guinea pig heart preparations.
    Stehr SN; Christ T; Rasche B; Rasche S; Wettwer E; Deussen A; Ravens U; Koch T; Hübler M
    Anesth Analg; 2007 Sep; 105(3):641-7. PubMed ID: 17717217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electromechanical dissociation and possible uncoupling of phosphorylation following tachydysrhythmogenic dose of amrinone in the guinea-pig Langendorff heart preparation.
    Onuaguluchi G; Tanz RD
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):81-97. PubMed ID: 6497512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the cardiotonic effects of milrinone, a new and potent cardiac bipyridine, on isolated tissues from several animal species.
    Alousi AA; Stankus GP; Stuart JC; Walton LH
    J Cardiovasc Pharmacol; 1983; 5(5):804-11. PubMed ID: 6195468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive inotropic action of amrinone: effect of elevated external Ca2+.
    Rendig SV; Amsterdam EA
    J Cardiovasc Pharmacol; 1984; 6(2):293-9. PubMed ID: 6200719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentration-response curves of positive inotropic agents before and after ouabain pretreatment.
    Brown L; Erdmann E
    Cardiovasc Res; 1985 May; 19(5):288-98. PubMed ID: 3995524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of amrinone on contractility and taurine influx in rat and guinea pig hearts.
    Azari J; Huxtable RJ
    Eur J Pharmacol; 1980 Oct; 67(4):347-53. PubMed ID: 6256173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amrinone and energy output of rabbit papillary muscles.
    Gibbs CL; Wendt IR
    J Cardiovasc Pharmacol; 1985; 7(2):267-72. PubMed ID: 2581079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for the cardiovascular activities of amrinone and AR-L57.
    Hayes JS; Bowling N; Boder GB; Kauffman R
    J Pharmacol Exp Ther; 1984 Jul; 230(1):124-32. PubMed ID: 6086873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of amrinone on contraction and K+-induced contracture of normal and subacutely failed cat ventricular muscle.
    Gaide MS; Kimura S; Lodge NJ; Cameron JS; Kozlovskis PL; Myerburg RJ; Bassett AL
    Circulation; 1986 Mar; 73(3 Pt 2):III36-45. PubMed ID: 3943180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of the bipyridines: amrinone and milrinone.
    Alousi AA; Johnson DC
    Circulation; 1986 Mar; 73(3 Pt 2):III10-24. PubMed ID: 2417744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inotropic effect of amrinone in rabbit papillary muscle: reversal of the myocardial depressant effect of halothane.
    Komai H; Rusy BF
    Can J Physiol Pharmacol; 1984 Nov; 62(11):1382-6. PubMed ID: 6509385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amrinone effects on electromechanical coupling and depolarization-induced automaticity in ventricular muscle of guinea pigs and ferrets.
    Malécot CO; Arlock P; Katzung BG
    J Pharmacol Exp Ther; 1985 Jan; 232(1):10-9. PubMed ID: 3965687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.